Alena Cristina Jaime‐Ramirez,Elizabeth L. McMichael,SriVidya Kondadasula,Cassandra C. Skinner,Bethany L. Mundy-Bosse,Eric Luedke,Natalie Jones,Aruna Mani,Julie M. Roda,Volodymyr Karpa,Hong Li,Jilong Li,Saranya Elavazhagan,Krista M. La Perle,Alessandra C. Schmitt,Yanhui Lu,Xiaoli Zhang,Xueliang Pan,Hsaioyin Mao,Melanie E. Davis,David Jarjoura,Jonathan P. Butchar,Ming Poi,Mitch A. Phelps,Susheela Tridandapani,John C. Byrd,Michael A. Caligiuri,Robert J. Lee,William E. Carson

Supplementary Figure Legend from Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity Via Membrane-Bound Transforming Growth Factor-β1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legends from Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Supplementary Figure from the Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells

Supplementary Figure Legends from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplemental Figure Legends from Membrane IL1α Inhibits the Development of Hepatocellular Carcinoma Via Promoting T- and NK-cell Activation

Supplemental Figure 1 from CTLA-4 Limits Anti-CD20–Mediated Tumor Regression

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Supplementary Fig. S8 from Addressing Tumor Heterogeneity by Sensitizing Resistant Cancer Cells to T cell–Secreted Cytokines

Supplemental Figure 6 from CTLA-4 Limits Anti-CD20–Mediated Tumor Regression

Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using in Vitro Genetically Modified Targeted Dendritic Cells

Supplementary Figure from Thymosin Α-1 Reverses M2 Polarization of Tumor-Associated Macrophages During Efferocytosis

Supplementary Figure 8 from TGF-β Signaling in Myeloid Cells is Required for Tumor Metastasis

Supplementary Figure Legend from Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody

Supplemental Figure S5 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Supplementary Figure Legends from NK Cell–Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines